HopeAndHelp.com
Title
ARIMIDEX - Postmenopausal Women with Hormone Receptor-Positive Early Breast Cancer
Description
Excerpted from the website description:
- Learn about ARIMIDEX approved for postmenopausal women with hormone receptor-positive early breast cancer.
Languages
English
Address
- 15 Stanhope Gate .
- London W1K 1LN UNITED KINGDOM
Contact
- AstraZeneca UK Ltd, Domains Administration
-
- +1 610 695 1211, Fax: +1 302 886 2309
Additional Information
Related Domains
External Links
Categories:
- ATAC STUDY
- Advanced Breast Cancer
- Advanced Breast Cancer Treatment
- Anastrozole
- Arimidex
- Arimidex Side Effects
- Astrazeneca
- Bone Health
- Breast Cancer
- Breast Cancer Awareness
- Breast Cancer Awareness Month
- Breast Cancer Clinical Trials
- Breast Cancer Hormonal Treatment
- Breast Cancer Recurrence
- Breast Cancer Stages
- Breast Cancer Support
- Breast Cancer Support Group
- Breast Cancer Therapy
- Breast Cancer Treatment
- Breast Cancer Treatments
- Breast Reconstruction
- Breast Self-exam
- Cancer
- Clinical Trials
- Early Breast Cancer
- Hormone Estrogen
- Hot Flashes
- How Arimidex Works
- Lumpectomy
- Lymphedema
- Mastectomy
- Metastatic Breast Cancer
- Of
- Reduce
- Risk
- Stages Of Breast Cancer
- Symptoms Of Breast Cancer
- The
- Vaginal Dryness